Joe Biden to visit Pfizer factory as Americans clamor for more COVID-19 vaccine supply

Biden is due to tour Pfizer's largest manufacturing site and its only facility in the United States making the COVID-19 vaccine at a time when less than 15% of the U.S. population is vaccinated.

Reuters
February 19, 2021 / 10:57 AM IST

Source: AP

President Joe Biden heads to Kalamazoo, Michigan, on Friday to visit the Pfizer Inc manufacturing plant that is churning out COVID-19 vaccines, as state and local governments across the country clamor for more.

Biden is due to tour Pfizer's largest manufacturing site and its only facility in the United States making the COVID-19 vaccine at a time when less than 15% of the U.S. population is vaccinated.

The United States has rolled out ambitious vaccination programs in recent weeks that include large sites capable of putting shots into thousands of arms daily, as well as hospitals and pharmacies. But officials are begging for more doses.

The Biden administration has been working to increase the number of doses it sends out to states, cities and pharmacies every week, but Dr. Anthony Fauci, Biden's top medical adviser, said on Tuesday that demand far outpaced supply at the moment.

The White House said earlier this month it was using the Defense Production Act to help Pfizer get additional equipment fast so that it could keep ramping up production. Biden is expected to discuss that initiative - which officials say is starting to pay dividends - with Pfizer executives during his tour.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials told Reuters. Jeff Williams, mayor of Arlington, Texas, who met with Biden and Treasury Secretary Janet Yellen in recent weeks, said his city of 400,000 was ready to vaccinate 40,000 people a day but only had enough supply to administer 3,000 doses.

300 MILLION DOSES

Pfizer is under contract to supply the United States with 300 million doses of the two-dose vaccine it developed with Germany’s BioNTech SE. The company has said it will provide the U.S. government with 100 million doses by the end of March and another 100 million by the end of May. It has promised the full 300 million doses by the end of July.

As of the end of January, Pfizer had supplied the U.S. government with about 29 million doses of the vaccine. That is about as many doses that had been used by Wednesday, according to U.S. Centers for Disease Control and Prevention data.

Moderna Inc, which is also producing COVID-19 vaccine domestically, has agreed to supply the United States with 300 million doses of its own two-dose vaccine by the end of July. Biden told a CNN town hall on Tuesday that everyone who wanted a vaccine should be able to get one by July, but said the recovery from the pandemic that has killed more than 485,000 people in the United States would still take many months.

Globally, Pfizer and BioNTech aim to make 2 billion doses of the COVID-19 vaccine this year. Pfizer’s chief financial officer told Reuters earlier this month that it had recently doubled the size of the batches of its vaccine and increased the number of batches it was producing.

Pfizer is one of the largest employers in the Kalamazoo area, a Democratic-leaning county in the electoral battleground state, which Biden carried in the November election.
Reuters
TAGS: #coronavirus #Covid-19 #Joe Biden #Pfizer #World News
first published: Feb 19, 2021 10:53 am